Seasonal And Perennial Allergies

Tezepelumab reduced exacerbations among patients with severe, uncontrolled asthma across all seasons regardless of their specific seasonal and perennial allergies, according to a study published in Annals of Allergy, Asthma & Immunology.

Tezepelumab reduced exacerbations among patients with severe, uncontrolled asthma across all seasons regardless of their specific seasonal and perennial allergies, according to a study published in Annals of Allergy, Asthma & Immunology.

Dextenza demonstrated a statistically significant mean change in ocular itching scores from baseline in patients with allergic conjunctivitis, according to a press release from Ocular Therapeutix.